Halozyme Therapeutics, Inc. (HALO) Earnings
NASDAQ·Healthcare·Biotechnology
$128.40
+0.30%
Mkt Cap $14.13B
EPS — Estimate vs Actual
Mkt Cap
$14.13B
P/E
51.56
Fwd P/E
7.47
P/S
10.12
Rev TTM
—
EPS TTM
$2.49
NASDAQ·Healthcare·Biotechnology
$128.40
+0.30%
Mkt Cap $14.13B
Mkt Cap
$14.13B
P/E
51.56
Fwd P/E
7.47
P/S
10.12
Rev TTM
—
EPS TTM
$2.49